Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout
Author:
Affiliation:
1. Centre for Health Economic and Medicines Evaluation; Bangor University; Bangor UK
2. Pharmacometrics; Pfizer Ltd; Sandwich UK
3. Department of Biostatistics; University of Liverpool; Liverpool UK
Funder
Medical Research Council
European Union's Convergence European Regional Development Fund
MRC North-West HTMR
MRC Network of Hubs for Trial Methodological Research (HTMR)
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13427/fullpdf
Reference46 articles.
1. Gout;Dalbeth;Lancet,2016
2. 2016 updated EULAR evidence-based recommendations for the management of gout;Richette;Ann Rheum Dis,2017
3. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney;Miner;Arthritis Res Ther,2016
4. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis;Pak;Urology,2002
5. Benzbromarone as a long-term uricosuric agent;Bluestone;Adv Exp Med Biol,1980
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies;Seminars in Arthritis and Rheumatism;2023-12
2. Changes in Urinary Uric Acid Concentration after Dotinurad Administration to Patients with Hyperuricemia: A Post Hoc Analysis of Two Clinical Trials in Japan;Clinical Pharmacology in Drug Development;2023-08-09
3. Non-Adherence in Adult Male Patients with Community-Acquired Pneumonia: Relative Forgiveness of Amoxicillin versus Respiratory Fluoroquinolones;Antibiotics;2023-05-01
4. Serum uric acid variability increases the risk of postoperative chronic kidney disease in patients with renal cell carcinoma after radical nephrectomy;Urologic Oncology: Seminars and Original Investigations;2021-08
5. A semi-mechanistic exposure–response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseases;Journal of Pharmacokinetics and Pharmacodynamics;2021-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3